BE553401A - - Google Patents

Info

Publication number
BE553401A
BE553401A BE553401DA BE553401A BE 553401 A BE553401 A BE 553401A BE 553401D A BE553401D A BE 553401DA BE 553401 A BE553401 A BE 553401A
Authority
BE
Belgium
Prior art keywords
phenyl
piperidine
ethyl
added
propionoxy
Prior art date
Application number
Other languages
English (en)
French (fr)
Publication of BE553401A publication Critical patent/BE553401A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE553401D BE553401A (es)

Publications (1)

Publication Number Publication Date
BE553401A true BE553401A (es)

Family

ID=178230

Family Applications (1)

Application Number Title Priority Date Filing Date
BE553401D BE553401A (es)

Country Status (1)

Country Link
BE (1) BE553401A (es)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317548A (en) * 1964-10-30 1967-05-02 Rexall Drug Chemical 1-allyl-3-(substituted benzoyl)-4-(substituted phenyl)-4-hydroxypiperidines
DE1294381B (de) * 1961-03-06 1969-05-08 Boehringer Sohn Ingelheim 1-Cinnamyl-4-(3'-hydroxyphenyl)-4-propionylpiperidin, dessen Saeureadditionssalze sowie Verfahren zu deren Herstellung

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1294381B (de) * 1961-03-06 1969-05-08 Boehringer Sohn Ingelheim 1-Cinnamyl-4-(3'-hydroxyphenyl)-4-propionylpiperidin, dessen Saeureadditionssalze sowie Verfahren zu deren Herstellung
US3317548A (en) * 1964-10-30 1967-05-02 Rexall Drug Chemical 1-allyl-3-(substituted benzoyl)-4-(substituted phenyl)-4-hydroxypiperidines

Similar Documents

Publication Publication Date Title
EP1708994B1 (fr) Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique
CA1280115C (fr) Derives de benzo¬b| thiophene et benzo¬b| furannecarboxamides, leurs procedes de preparation et les medicaments les contenant
WO2005090322A1 (fr) Derives de alkylpiperazine- et alkylhomopiperazine- carboxylates, leur preparation et leur application en tant qu’inhibiteurs de l’enzyme faah
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
WO2005090347A1 (fr) Derives d’aryl- et d’heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah
EP0101381B1 (fr) Trifluorométhylphényltétrahydropyridines à activité anorexigène, un procédé de préparation et compositions pharmaceutiques
FR2493315A1 (fr) Derive de piperazine, procede pour sa preparation et composition analgesique en contenant
FR2595695A1 (fr) Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
EP0069664A1 (fr) Amidobenzamides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant
CH649994A5 (fr) Derives du 4h-1,2,4-triazole, procedes de preparation et compositions les renfermant.
FR2477150A1 (fr) Nouveaux derives heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les comportant
CH630606A5 (en) Phenylamidine derivatives useful especially in therapeutics
WO1999062900A1 (fr) Derives d'oxindole utile comme antagonistes des recepteurs de neurokinines
BE553401A (es)
EP0101379B1 (fr) Benzamides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant
EP0176444B1 (fr) Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant
CA1100968A (fr) Procedes de preparation de nouvelles piperazines disubstituees
EP0275762B1 (fr) Dérivés de l'indole carboxamide ainsi que leurs sels, procédé et intermédiaires de préparation, application à titre de médicaments de ces dérivés et compositions les renfermant
CH661512A5 (fr) 1-pyridyloxy-3-indolylalkylamino-propanols substitues et leur preparation.
EP0687252A1 (fr) Derives de la phenoxy-2 ethylamine, leur preparation et leur application en therapeutique
CH620678A5 (en) Process for the preparation of a derivative of piperidine
EP0099822B1 (fr) Nouveaux 1-(2-carbalkoxy 4-(thiénylalkylamido)phénoxy) 3-amino 2-propanols, leur préparation et leurs applications en thérapeutique
EP0094303B1 (fr) Amides, leurs sels, procédé pour leur préparation et compositions pharmaceutiques les renfermant
EP0103500A2 (fr) Dérivés de phénéthyl-1alpha-phényl-pipéridine-3-propanenitrile, leur préparation et leur application en thérapeutique
FR2523129A1 (fr) Derives de 3-azetidinylethyl-1-phenyl-2-imidazolidinone, medicaments les contenant et procede pour leur preparation